Cancer diagnostics company Pacific Edge (NZX, ASX: PEB) releases its investor update for the three months to the end of December 2025 (Q3 26) today with reports on further strategic achievements to ...
Pacific Edge (PEB), a cancer diagnostics company, today released its investor update for the three months ending December ...
Fintel reports that on January 12, 2026, Baird upgraded their outlook for Pebblebrook Hotel Trust (NYSE:PEB) from Neutral to ...
Fintel reports that on January 6, 2026, Barclays initiated coverage of Pebblebrook Hotel Trust (NYSE:PEB) with a Underweight ...